Cellcept is the brand name for the medication mycophenolate mofetil, which is commonly used in transplant medicine to prevent rejection of transplanted organs, such as kidneys, heart, or liver. It belongs to a class of medications known as immunosuppressants.
Cellcept works by suppressing the activity of certain cells in the immune system that would otherwise attack the transplanted organ.
The drug is typically taken orally, either as a tablet or a liquid suspension. It is often prescribed in combination with other immunosuppressive medications to optimize its effectiveness while minimizing side effects.
Common side effects of Cellcept may include gastrointestinal symptoms like nausea, vomiting, diarrhea, and abdominal pain, as well as an increased risk of infections due to its effects on the immune system. Patients taking Cellcept require close monitoring by healthcare professionals to ensure appropriate dosing and to manage any potential side effects or complications.